Wall Street Experts
ver. ZuMIgo(08/25)
Prognozy (mln) dla Edwards Lifesciences Corporation
Okres |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
Przychód (średnia) |
5,910.07 |
6,474.41 |
7,154.07 |
7,959.41 |
8,672.84 |
Przychód Δ r/r |
0.00% |
9.55% |
10.50% |
11.26% |
8.96% |
Przychód (min) |
5,889.73 |
6,302.52 |
7,137.53 |
7,822.58 |
8,523.74 |
Przychód (max) |
5,960.94 |
6,686.19 |
7,170.61 |
8,112.48 |
8,839.63 |
EBITDA (średnia) |
1,861.48 |
2,039.23 |
2,253.30 |
2,506.96 |
2,731.67 |
EBIT (średnia) |
1,689.23 |
1,850.53 |
2,044.79 |
2,274.97 |
2,478.89 |
EBIT % |
28.58% |
28.58% |
28.58% |
28.58% |
28.58% |
Zysk netto (średni) |
1,480.29 |
1,579.71 |
1,759.66 |
2,122.24 |
2,369.63 |
Zysk netto % |
25.05% |
24.40% |
24.60% |
26.66% |
27.32% |
EPS (średnia) |
2.47 |
2.76 |
3.11 |
3.54 |
3.95 |
Liczba analityków (Przychody) |
22 |
31 |
23 |
14 |
11 |
Liczba analityków (EPS) |
22 |
22 |
9 |
4 |
3 |
symbol |
EW |
EW |
EW |
EW |
EW |